Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Rheumatology

• Publication date

  2018-04-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-018-4100-8PMID 29679168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Involvement in Systemic Vasculitis

  2017cited by this paper
• Vasculitis for the internist: focus on ANCA-associated vasculitis

  2017cited by this paper
• Renal replacement therapy in acute kidney injury from a Chinese cross-sectional study: patient, clinical, socioeconomic and health service predictors of treatment

  2017cited by this paper
• Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis

  2017cited by this paper
• Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

  2014cited by this paper
• 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

  2013cited by this paper
• Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center.

  2013cited by this paper
• Notice

  2012cited by this paper
• Notice

  2012cited by this paper
• KDIGO Clinical Practice Guidelines for Acute Kidney Injury

  2012cited by this paper
• Renal replacement therapy in adult critically ill patients: when to begin and when to stop.

  2010cited by this paper
• Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic AntibodyAssociated Vasculitis

  2009cited by this paper
• Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.

  2007cited by this paper
• Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.

  2006cited by this paper
• A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

  2003cited by this paper
• The Churg Strauss syndrome (allergic granulomatous angiitis): review and update.

  2003cited by this paper
• Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

  2003cited by this paper
• Rapidly progressive crescentic glomerulonephritis.

  2003cited by this paper
• Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

  2002cited by this paper
• The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review.

  2001cited by this paper
• Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis.

  1999cited by this paper
• Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.

  1998cited by this paper
• Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide.

  1998cited by this paper
• A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.

  1997cited by this paper
• Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide

  1997cited by this paper
• Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.

  1996cited by this paper
• The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement

  1996cited by this paper
• The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement.

  1996cited by this paper
• Cyclophosphamide pulse therapy in Wegener's granulomatosis.

  1991cited by this paper
• Effect of urinary extracts from salt-loaded man on urinary sodium excretion by the rat.

  1972cited by this paper

• Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT)

  2024cites this paper
• Treatment Updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) Vasculitis.

  2021cites this paper
• Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.

  2020cites this paper
• Is Renal Function Recovery and Discontinuation of Long Term Hemodialysis Possible in Patients with Presumed End Stage Kidney Disease? The Role of Toprak’s Kidney Care

  2020cites this paper
• Circulating nicotinamide adenine dinucleotide-ubiquinone oxidoreductase chain 6 is associated with disease activity of anti-neutrophil cytoplasmic antibody-associated vasculitis.

  2020cites this paper
• Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study

  2019cites this paper